Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Choline Bitartrate Market

Choline Bitartrate Market Share

Report ID: GMI5241
Published Date: Mar 2022
Report Format: PDF

Download Free Sample

Choline Bitartrate Market Share

The global choline bitartrate market is fragmented in nature with presence of both large and small manufacturers.

Balchem Inc
Glentham Life Sciences Limited
Cepham Life Sciences
Finetech Industry Limited
Arochem Industries
Salvi Chemical Industries Ltd
Alfa Aesar
Jinan Pengbo Biotechnology Co., Ltd.
NutriScience Innovations, LLC
TCI Chemicals (India) Pvt. Ltd.

are few manufacturers present in the market.

Manufacturers are continuously investing in R&D to improve quality and transparency in manufacturing. Key players are also engaged in strategic initiatives such as capacity expansion, merger, and acquisition to expand its foothold in industry and increase its market share in the foreseeable timeframe.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

The global choline bitartrate industry size had crossed USD 410 million in 2021 and is poised to record a 6% CAGR between 2022 and 2028 owing to growing adoption in the synthesis of sphingomyelin and phosphatidylcholine.

Choline bitartrate plays an essential role in lipid transportation, supporting cell membrane, healthy metabolism, DNA synthesis as well as early brain development.

The baby food application segment in the choline bitartrate market is pegged to register over USD 185 million by 2028 on account of the thriving need for brain development.

The choline bitartrate market in North America is expected to generate USD 215 million in annual revenue by 2028 due to the robust presence of a large number of pharmaceutical as well as nutraceutical companies.